Old Web
English
Sign In
Acemap
>
authorDetail
>
Deborah White
Deborah White
Novartis
Cancer research
Imatinib
Medicine
Nilotinib
Biology
5
Papers
2
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Running head: Imatinib Cessation After Stable UMRD in CML
2017
David M. Ross
Susan Branford
John F Seymour
Christopher Arthur
David T. Yeung
Phuong Dang
Cassandra Slader
Robin Filshie
Anthony K. Mills
Deborah White
Andrew P Grigg
Timothy P. Hughes
Show All
Source
Cite
Save
Citations (0)
depletes CML progenitor and stem cells with CSL362 effectively α Monoclonal antibody targeting of IL-3 receptor
2014
Angel Francisco Lopez
Timothy P. Hughes
Deborah White
Devendra K. Hiwase
Eva Nievergall
Hayley S. Ramshaw
Agnes S. M. Yong
Mark Biondo
Samantha Busfield
Show All
Source
Cite
Save
Citations (1)
of low in vitro sensitivity to imatinib imatinib but not nilotinib (AMN107): reduced OCT-1 activity is the cause OCT-1-mediated influx is a key determinant of the intracellular uptake of
2010
Carol B. Cambareri
Steven Quinn
Paul W. Manley
Timothy P. Hughes
Deborah White
Verity A. Saunders
Phuong Dang
Jane Engler
Andrew C.W. Zannettino
Show All
Source
Cite
Save
Citations (0)
Verfahren zur optimierung der behandlung von philadelphia-positiver leukämie mit imatinib mesylat
2009
Yanfeng Wang
Thea Kalebic
Timothy P. Hughes
Deborah White
Show All
Source
Cite
Save
Citations (0)
Proton pump inhibitors interact with transport of both imatinib and nilotinib.
2007
Cancer Research
Deborah White
Verity Saunders
Steven Quinn
Paul W. Manley
Timothy P. Hughes
Show All
Source
Cite
Save
Citations (1)
1